视网膜母细胞瘤动脉内化疗后发生孔源性视网膜脱离:2016年创始人奖讲座
回顾性病例系列评估视网膜母细胞瘤经动脉内化疗(IAC)后孔源性视网膜脱离(RRD)的发生情况。167眼中10眼(6%)发生RRD,多与肿瘤快速消退后萎缩性视网膜裂孔相关,多见于晚期眼内广泛内生型肿瘤。
要点
- 167眼中10眼(6%)在IAC后发生RRD,多位于IAC后1个月内(8眼)或12个月内(2眼)。
- 原发IAC组RRD发生于E组5/30(17%,P=0.0348)和内生型5/22(23%,P=0.0073)。
- RRD主要原因为肿瘤消退相关萎缩性裂孔(7/10,70%),4/10眼(40%)伴增生性玻璃体视网膜病变。
核心结论
- 视网膜母细胞瘤IAC后RRD发生率为6%,多发生于晚期眼内广泛内生型肿瘤,一般源于肿瘤快速消退后的萎缩性视网膜裂孔。
研究设计与样本
- 回顾性病例系列,纳入157例连续患者的167眼,诊断视网膜母细胞瘤时平均年龄19个月。
主要发现
- 167眼中10眼(6%)在IAC后发生RRD,RRD多与肿瘤快速消退伴萎缩性视网膜裂孔相关,发生于IAC后1个月内(8眼)或12个月内(2眼)。
- 原发IAC后发生RRD 6/75(8%),继发IAC后发生RRD 4/92(4%)。
- 原发IAC组中,RRD见于D组1/38(3%,P=0.1075)或E组5/30(17%,P=0.0348)。
- 原发IAC组(75眼)中,RRD见于内生型5/22(23%,P=0.0073)、外生型0/29(0%,P=0.0760)或混合内生/外生型1/24(4%,P=0.6575)。
- RRD眼(10眼)与无RRD眼(157眼)比较:就诊时平均年龄更大(38个月 vs 18个月,P=0.0522)、4象限玻璃体种植更多(5/10,50% vs 27/157,17%,P=0.0236)、无视网膜下液更多(3/10,30% vs 102/157,65%,P=0.0236)。
关键数值与推荐
- RRD原因:肿瘤消退相关萎缩性视网膜裂孔7/10(70%)(单灶1/10,10%;多灶6/10,60%)、冷冻治疗所致单个萎缩性裂孔2/10(20%)、后玻璃体脱离所致单个瓣状撕裂1/10(10%)。
- 4/10眼(40%)RRD伴增生性玻璃体视网膜病变。
- RRD与玻璃体内注射无关:原发IAC无既往注射,继发IAC注射在数月前进行。
- 原发RRD修复:玻璃体切割术3眼、巩膜扣带术不引流1眼、激光屏障1眼、观察5眼。
- 平均随访24个月后,视网膜完全复位3/10(30%)、部分复位2/10(20%)、所有观察眼持续脱离5/10(50%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate rhegmatogenous retinal detachment (RRD) in eyes with retinoblastoma after intraarterial chemotherapy (IAC). DESIGN: Retrospective case series. METHODS: Chart review. MAIN OUTCOME MEASURE: Development of RRD in the IAC era. RESULTS: Of 167 eyes in 157 consecutive patients, mean patient age at diagnosis of retinoblastoma was 19 months. Intraarterial chemotherapy was primary (75/167, 45%) or secondary (92/167, 55%). There were 10 eyes (10/167, 6%) that developed RRD after IAC. The RRD was mostly related to rapid tumor regression with atrophic retinal hole, occurring within one month (n = 8) or 12 months (n = 2) of IAC. Rhegmatogenous retinal detachment was found after primary (6/75, 8%) or secondary (4/92, 4%) IAC. Of primary cases, RRD was found in Group D (1/38 [3%], P = 0.1075) or Group E (5/30 [17%], P = 0.0348). For primary IAC (n = 75 eyes), RRD was found in endophytic (5/22 [23%], P = 0.0073), exophytic (0/29 [0%], P = 0.0760), or combined endophytic/exophytic pattern (1/24 [4%], P = 0.6575). A comparison of eyes with RRD (n = 10) versus without RRD (n = 157) found significant differences including greater mean age at presentation (38 vs. 18 months, P = 0.0522), greater 4-quadrant vitreous seeding (5/10, 50% vs. 27/157, 17%, P = 0.0236), and absence of subretinal fluid (3/10, 30% vs. 102/157, 65%, P = 0.0236). The cause of RRD was tumor regression-related atrophic retinal hole(s) in 7 (7/10, 70%) (unifocal [1/10, 10%] or multifocal [6/10, 60%] holes), cryotherapy-induced single atrophic hole in 2 (2/10, 20%), and single flap-tear from posterior vitreous detachment in one (1/10, 10%). In 4 (4/10, 40%) eyes with RRD, proliferative vitreoretinopathy was noted. The RRD was not related to intravitreal injection in any case, as in primary IAC no case had previous injection and in secondary IAC the injections were performed many months previously. Primary RRD repair involved pars plana vitrectomy in three, scleral buckle without drainage in one, laser barricade in one, and observation in five eyes. After 24 months mean follow-up, the retina showed complete reattachment (3/10, 30%), partial reattachment (2/10, 20%), and persistent detachment in all observed eyes (5/10, 50%). Enucleation was necessary for tumor recurrence (4/10, 40%) or neovascular glaucoma (1/10, 10%). There were no tumor-related metastases or death. CONCLUSION: After IAC for retinoblastoma, RRD occurs in 6%, mostly in advanced eyes with extensive endophytic tumor and generally from atrophic retinal hole after rapid tumor regression.
引用
- Shields CL, Say EAT, Pefkianaki M, et al. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture. Retina. 2017. PMID: 27787452. doi:10.1097/IAE.0000000000001382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。